Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Aquaporins

Aquaporins

Aquaporins or AQPs are a family of integral membrane proteins whose primary function is to transport water, while some called aquaglyceroporins also transport glycerol. In addition, aquaporins have also been suspected to be involved in transporting volatile substances, such as carbon dioxide and ammonia, across membranes. Such AQPs that act as gas channels are often highly expressed in cells involved in the gaseous exchange, such as red blood cells, epithelial cells, and pulmonary capillaries.

Apoptosis

Apoptosis

Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size...

The Proteasome

The Proteasome

Eukaryotic cells can degrade proteins through several pathways. One of the most important amongst these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...

Interactions Between Signaling Pathways

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

A Vein Attempt? Experimental Models for Arteriovenous Fistula Research.

Cardiovascular engineering and technology·2026

Same author

Interventions to improve adherence among patients prescribed statins for primary prevention of cardiovascular diseases: A systematic review and meta-analysis.

European journal of preventive cardiology·2026

Same author

Targeting excessive cholesterol deposition alleviates secondary lymphoedema.

Nature·2026

Same author

HDL metabolism and function in diabetes mellitus.

Nature reviews. Endocrinology·2025

Same author

A change of heart: the effect of high flow arteriovenous fistulas on cardiovascular outcomes - a systematic review and synthesis without meta-analysis (SWiM).

BMC nephrology·2025

Same author

Copper chelation redirects neutrophil function to enhance anti-GD2 antibody therapy in neuroblastoma.

Nature communications·2024

Search research articles

Related Experiment Video

Updated: Nov 17, 2025

Studying Protein Function and the Role of Altered Protein Expression by Antibody Interference and Three-dimensional Reconstructions

Studying Protein Function and the Role of Altered Protein Expression by Antibody Interference and Three-dimensional Reconstructions

Published on: April 21, 2016

APOA1: a Protein with Multiple Therapeutic Functions.

Blake J Cochran¹, Kwok-Leung Ong¹, Bikash Manandhar¹

¹Lipid Research Group, School of Medical Sciences, Faculty of Medicine, University of New South Wales Sydney, Level 4E Wallace Wurth Building, Kensington, New South Wales, 2052, Australia.

Current Atherosclerosis Reports

|February 16, 2021

Summary

This summary is machine-generated.

Apolipoprotein A1 (APOA1), a key component of HDL, shows significant therapeutic potential beyond heart health. Emerging research highlights its benefits in various diseases, with new peptide and synthetic HDL therapies under development.

Keywords:

APOA1 Atherosclerosis Cancer Diabetes Neurological disorders Thrombosis

More Related Videos

Production of Monoclonal Antibodies Targeting Aminopeptidase N in the Porcine Intestinal Mucosal Epithelium

Production of Monoclonal Antibodies Targeting Aminopeptidase N in the Porcine Intestinal Mucosal Epithelium

Published on: May 18, 2021

Overlapping Peptide Library to Map Qa-1 Epitopes in a Protein

Overlapping Peptide Library to Map Qa-1 Epitopes in a Protein

Published on: December 20, 2017

Related Experiment Videos

Last Updated: Nov 17, 2025

Studying Protein Function and the Role of Altered Protein Expression by Antibody Interference and Three-dimensional Reconstructions

Studying Protein Function and the Role of Altered Protein Expression by Antibody Interference and Three-dimensional Reconstructions

Published on: April 21, 2016

Production of Monoclonal Antibodies Targeting Aminopeptidase N in the Porcine Intestinal Mucosal Epithelium

Production of Monoclonal Antibodies Targeting Aminopeptidase N in the Porcine Intestinal Mucosal Epithelium

Published on: May 18, 2021

Overlapping Peptide Library to Map Qa-1 Epitopes in a Protein

Overlapping Peptide Library to Map Qa-1 Epitopes in a Protein

Published on: December 20, 2017

Area of Science:

Cardiovascular Science
Biochemistry
Therapeutics

Background:

Apolipoprotein A1 (APOA1) is the primary apolipoprotein in high-density lipoproteins (HDLs).
APOA1 possesses well-established cardioprotective functions.
Recent discoveries reveal additional beneficial roles for APOA1.

Purpose of the Study:

To review the therapeutic potential of Apolipoprotein A1 (APOA1).
To explore APOA1's functions across multiple disease states.
To discuss emerging APOA1-based therapeutic strategies.

Main Methods:

Literature review of recent findings on APOA1 functions.
Analysis of therapeutic applications in various diseases.
Examination of APOA1-mimicking peptides and reconstituted HDL (rHDL).

Main Results:

Growing evidence supports APOA1's beneficial roles in atherosclerosis, thrombosis, diabetes, cancer, and neurological disorders.
Development of clinically relevant peptides and synthetic rHDL preparations.
These agents are designed to replicate the functions of full-length APOA1.

Conclusions:

Apolipoprotein A1 (APOA1) is a multifunctional apolipoprotein with broad therapeutic potential.
Clinical translation hinges on the efficacy and bioavailability of novel APOA1-based therapies.
Ongoing investigations focus on peptides and synthetic rHDL for diverse disease treatments.